BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37797393)

  • 1. Long non-coding RNAs: The hidden players in diabetes mellitus-related complications.
    Hussein RM
    Diabetes Metab Syndr; 2023 Oct; 17(10):102872. PubMed ID: 37797393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of lncRNAs in Diabetes Mellitus: A Systematic Review and
    Dieter C; Lemos NE; Corrêa NRF; Assmann TS; Crispim D
    Front Endocrinol (Lausanne); 2021; 12():602597. PubMed ID: 33815273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes.
    Sathishkumar C; Prabu P; Mohan V; Balasubramanyam M
    Hum Genomics; 2018 Aug; 12(1):41. PubMed ID: 30139387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of Serum lncRNAs in Diabetic Retinopathy - A Potential Diagnostic Tool.
    Biswas S; Coyle A; Chen S; Gostimir M; Gonder J; Chakrabarti S
    Front Endocrinol (Lausanne); 2022; 13():851967. PubMed ID: 35464068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rs3931283/PVT1 and rs7158663/MEG3 polymorphisms are associated with diabetic kidney disease and markers of renal function in patients with type 2 diabetes mellitus.
    Dieter C; Lemos NE; Girardi E; Ramos DT; Pellenz FM; Canani LH; Assmann TS; Crispim D
    Mol Biol Rep; 2023 Mar; 50(3):2159-2169. PubMed ID: 36565414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Oxidative Stress by Long Non-Coding RNAs in Vascular Complications of Diabetes.
    Chu PM; Yu CC; Tsai KL; Hsieh PL
    Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs: From disease code to drug role.
    Chen Y; Li Z; Chen X; Zhang S
    Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications.
    Zhu L; Li Y; Xia F; Xue M; Wang Y; Jia D; Gao Y; Li L; Shi Y; Chen S; Xu G; Yuan C
    Curr Pharm Des; 2022; 28(12):1011-1018. PubMed ID: 34895118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA as a regulator in the development of diabetic complications.
    Geng M; Liu W; Li J; Yang G; Tian Y; Jiang X; Xin Y
    Front Endocrinol (Lausanne); 2024; 15():1324393. PubMed ID: 38390204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of long noncoding RNAs on gastric cancer.
    Li T; Mo X; Fu L; Xiao B; Guo J
    Oncotarget; 2016 Feb; 7(8):8601-12. PubMed ID: 26788991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.
    Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD
    BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNAs in Diabetes and Diabetic Complications.
    Leung A; Natarajan R
    Antioxid Redox Signal; 2018 Oct; 29(11):1064-1073. PubMed ID: 28934861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells.
    Özgür E; Mert U; Isin M; Okutan M; Dalay N; Gezer U
    Clin Exp Med; 2013 May; 13(2):119-26. PubMed ID: 22487937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review.
    Momtazmanesh S; Rezaei N
    Front Oncol; 2021; 11():712786. PubMed ID: 34322395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.
    Alfaifi M; Ali Beg MM; Alshahrani MY; Ahmad I; Alkhathami AG; Joshi PC; Alshehri OM; Alamri AM; Verma AK
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33436407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Long Non-Coding RNAs and the Molecular Mechanisms Involved in Insulin Resistance.
    Tello-Flores VA; Beltrán-Anaya FO; Ramírez-Vargas MA; Esteban-Casales BE; Navarro-Tito N; Alarcón-Romero LDC; Luciano-Villa CA; Ramírez M; Del Moral-Hernández Ó; Flores-Alfaro E
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNA regulators of diabetic polyneuropathy.
    Meydan C; Üçeyler N; Soreq H
    Neurosci Lett; 2020 Jul; 731():135058. PubMed ID: 32454150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs TUG1 and MEG3 in patients with type 2 diabetes and their association with endoplasmic reticulum stress markers.
    Heydari N; Sharifi R; Nourbakhsh M; Golpour P; Nourbakhsh M
    J Endocrinol Invest; 2023 Jul; 46(7):1441-1448. PubMed ID: 36662419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis.
    Gao S; Zhao ZY; Wu R; Zhang Y; Zhang ZY
    Onco Targets Ther; 2018; 11():4877-4891. PubMed ID: 30147339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal Long Non-Coding RNAs in Lung Diseases.
    Poulet C; Njock MS; Moermans C; Louis E; Louis R; Malaise M; Guiot J
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.